Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the long-term safety, tolerability, and efficacy of
adjunctive therapy of LP352 in subjects with developmental and epileptic encephalopathies who
completed participation in Study LP352-201.